Goldman Sachs’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $22K | Sell |
|
|||||
|
2022
Q2 | $31K | Sell |
|
|||||
|
2022
Q1 | $84K | Sell |
|
|||||
|
2021
Q4 | $219K | Buy |
|
|||||
|
2021
Q3 | $281K | Buy |
|
|||||
|
2021
Q2 | $82K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $119K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $25K | Sell |
|
|||||
|
2018
Q3 | $371K | Buy |
|
|||||
|
2018
Q2 | $365K | Sell |
|
|||||
|
2018
Q1 | $507K | Sell |
|
|||||
|
2017
Q4 | $332K | Buy |
|
|||||
|
2017
Q3 | $321K | Buy |
|
|||||
|
2017
Q2 | $318K | Sell |
|
|||||
|
2017
Q1 | $348K | Buy |
|
|||||
|
2016
Q4 | $294K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $252K | Buy |
|